CD79A and COVID-19: Our results demonstrate that dIgA antibodies are detectable in humans infected with COVID‐19 before SARS‐CoV‐2–specific IgA, suggesting dIgA could play a role in the early stages of the immune response to SARS‐CoV‐2 infection.